子宫捐献用于移植后3年捐献者的健康相关生活质量与心理社会结局
本研究为瑞典首项子宫移植试验的完整前瞻性队列研究,纳入9名子宫捐献者(年龄39至62岁),在术后2年和3年通过问卷评估健康相关生活质量、情绪及婚姻关系。总体而言,捐献者上述指标相对稳定,但少数参与者出现轻度负向偏差,推测与年龄较大或捐献后受者持续未妊娠结局相关。
要点
- 子宫捐献后2至3年,捐献者健康相关生活质量、情绪及婚姻关系总体相对稳定。
- 3年时两位年龄最大捐献者(手术时>60岁)躯体健康得分明显负向偏差。
- 3年时3名捐献者心理健康得分轻度负向偏差,其中3人属于受者妊娠结局失败的4人。
核心结论
- 本研究提示,活体子宫捐献在2至3年随访期内总体不负面影响健康相关生活质量、情绪及伴侣关系。
- 需要更长时间随访、纳入更多捐献者并在不同文化背景中开展研究。
研究设计与样本
- 完整的前瞻性队列研究,纳入瑞典2013年首项子宫移植试验的全部9名捐献者。
- 捐献者均为受者的近亲或朋友,年龄39至62岁。
- 术后2年和3年通过问卷评估:SF-36测量健康相关生活质量躯体与心理成分总结,医院焦虑抑郁量表评估情绪,二元调整量表评估伴侣关系。
主要发现
- SF-36躯体与心理成分总体高于常模人群平均分。
- 第3年时两位年龄最大捐献者(手术时>60岁)躯体成分得分出现明显负向偏差。
- 第2年时SF-36心理成分总结总体基本无变化,但第3年时3名捐献者出现轻度负向偏差,这3人属于受者妊娠结局不成功的4名捐献者。
- 第2年所有捐献者焦虑和抑郁评分均在常模范围内,但第3年一名捐献者两项评分均升高(变差)。
- 随访期间两名捐献者出现关系困扰迹象,另一名已离婚。
局限性
- 样本量小是一项局限性。
- 需要更长时间随访、纳入更多捐献者并在不同文化背景中开展研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the effects on donors' health-related quality-of-life, mood and marital relationship 2 and 3 years after uterus donation for transplantation? SUMMARY ANSWER: Overall, uterus donors were relatively stable regarding health-related quality-of-life, mood and marital relationship after donation, although slight negative deviations existed in a few participants, presumably associated with older age or with continued non-pregnancy outcomes from the donation. WHAT IS KNOWN ALREADY: Uterus transplantation has recently proved to be a successful treatment for absolute uterine factor infertility. However, there is no previous research on health-related quality-of-life and long-term psychosocial outcomes of donors. The present cohort of nine donors represents the cases of the first clinical uterus transplantation study, which took place in Sweden. Long-term follow-up studies of health-related quality-of-life in other living donors, such as of kidneys and livers, suggest that donors have above average quality-of-life prior to donation and that this typically continues during the years after donation. In our previous 1-year report on psychosocial and quality-of-life outcomes, we found that two out of nine donors showed decreased health-related quality-of-life at 6 and 12 months post donation. STUDY DESIGN, SIZE, DURATION: This complete, prospective cohort study included the nine donors of the first uterus transplantation trial, which took place in Sweden in 2013. Donors were assessed by questionnaires 2 and 3 years after surgery for uterus donation. PARTICIPANTS/MATERIALS, SETTING, METHODS: The nine donors (aged 39 to 62 years) were all a close relative or friend of their recipient. Physical and mental component summaries of health-related quality-of-life were measured with the SF-36 questionnaire. Mood was assessed by the Hospital Anxiety Depression Scale. Relationship with partner was measured with the Dyadic Adjustment Scale. MAIN RESULTS AND THE ROLE OF CHANCE: The physical and mental components of the SF-36 were generally above the mean scores for a normative population. At Year 3, the two oldest donors (above 60 years of age at surgery) showed clear negative deviations in the physical component. The mental component summary of SF-36 was essentially unaltered overall at Year 2, but slight negative deviations were seen in three donors at Year 3. These three donors were among the four with unsuccessful pregnancy outcomes for the recipients following donation. Scores of anxiety and depression (mood) were within normative values for all donors at Year 2, but one donor presented with increased (worse) values for both variables at Year 3. Two donors showed signs of relationship distress during the follow-up period and another had divorced during this period. LIMITATIONS, REASONS FOR CAUTION: The small sample size is a limitation. WIDER IMPLICATIONS OF THE FINDINGS: The present study suggests that live uterus donation does not in general negatively influence health-related quality-of-life, mood and relationship in a 2 to 3-year perspective follow-up. Longer follow-up studies, including larger number of donors and in different cultural settings, are needed. STUDY FUNDING/COMPETING INTEREST(S): The Jane and Dan Olsson Foundation for Science; the Wallenberg Foundation; an ALF grant from the Swedish state under an agreement between the government and the county councils; the Swedish Research Council; a Ferring Pharmaceuticals scholarship in memory of Robert Edwards; and the Iris Jonzén-Sandbloms and Greta Jonzéns Foundation. The authors have no competing interests. TRIAL REGISTRATION NUMBER: NCT01844362.
引用
- Järvholm S, Kvarnström N, Dahm-Kähler P, et al. Donors' health-related quality-of-life and psychosocial outcomes 3 years after uterus donation for transplantation. Hum Reprod. 2019. PMID: 31241745. doi:10.1093/humrep/dez087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。